Nu Skin Enterprises, Inc. filings document the company’s operating results, governance, executive leadership changes and financing arrangements. Recent 8-K reports include quarterly and annual financial-result releases, officer appointments and resignations, compensation arrangements, and material definitive agreements tied to amended credit facilities.
The company’s proxy materials provide annual meeting governance and executive-compensation disclosures, including board and compensation matters reported under Schedule 14A. Nu Skin’s regulatory record also reflects its capital structure and liquidity arrangements, including term loan and revolving credit facilities, alongside formal disclosures for its beauty and wellness operations, affiliate platform and Rhyz-related business activities.
Nu Skin Enterprises Inc: The Vanguard Group reports it beneficially owns 0 shares (0%) of Nu Skin common stock following an internal realignment. The filing states certain Vanguard subsidiaries now report separately in reliance on SEC Release No. 34-39538 (January 12, 1998), and Vanguard no longer is deemed to beneficially own securities held by those subsidiaries. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Nu Skin Enterprises announced that Executive Vice President and Chief Financial Officer James D. Thomas resigned on March 17, 2026 to pursue an outside opportunity. On March 18, 2026, the board appointed Vice President and Corporate Controller Chelsea K. Lantz as Interim CFO while a search for a permanent CFO, including internal and external candidates, is conducted.
Lantz, age 42, has been with Nu Skin since 2011 in various finance and audit roles and became Corporate Controller in 2023. As Interim CFO she will receive a $300,000 annual salary, a target incentive bonus equal to 35% of salary, and a $25,000 stipend for each quarter she serves in the interim role. The company states there are no family relationships or related-person transactions involving her and expects to enter into a standard indemnification agreement. A press release dated March 20, 2026 announces her appointment and highlights her role in cost-improvement efforts that contributed to a significant year-over-year EPS increase.
NU SKIN ENTERPRISES director Edwina D. Woodbury acquired additional shares through a plan-related dividend reinvestment. On 2026-03-11, she received 14 shares of Class A Common Stock at $7.31 per share under the company’s Deferred Compensation Plan. Following this automatic, non-open-market transaction, she directly holds 42,993 shares.
Keisel Justin S reported acquisition or exercise transactions in this Form 4 filing.
NU SKIN ENTERPRISES, INC. executive Justin S. Keisel, EVP and President of Global Sales, received a grant of 47,059 shares of Class A Common Stock. The award was recorded at a price of $0.00 per share, indicating an equity grant rather than an open-market purchase. Following this grant, Keisel directly holds 160,170 shares of Nu Skin Class A Common Stock.
Nu Skin Enterprises Chief Product Officer Steven Keith Hatchett reported an equity award of 77,941 shares of Class A common stock on March 6, 2026. The shares were acquired as a grant with a reported price of $0.00 per share, indicating a non-cash award. Following this grant, Hatchett's directly held ownership increased to 260,818 shares of Nu Skin Class A common stock.
Nu Skin Enterprises executive Chayce David Clark received a large stock award that increases his direct ownership stake. On March 6, 2026, he was granted 138,971 shares of Nu Skin Class A Common Stock at no acquisition cost. After this grant, he directly owns 390,746 shares.
NU SKIN ENTERPRISES, INC. Chief Financial Officer Thomas James D received a grant of 114,706 shares of Class A Common Stock on March 6, 2026. The shares were awarded at a price of $0.00 per share, reflecting a stock grant rather than an open-market purchase.
Following this award, his directly held Class A Common Stock position increased to 267,102 shares. The transaction is coded as a grant, award, or other acquisition, indicating it was part of an equity award arrangement rather than a cash-funded transaction.
NU SKIN ENTERPRISES, INC. President and CEO Ryan S. Napierski reported receiving an equity grant of 282,353 shares of Class A Common Stock on March 6, 2026. The shares were acquired as a grant or award at a reported price of $0.00 per share. Following this award, his directly held stake increased to 1,001,905 Class A shares.
Nu Skin Enterprises appointed Chayce D. Clark as Executive Vice President, Chief Operating Officer and Chief Legal Officer. Clark has been the company’s Executive Vice President and General Counsel since 2021 after joining Nu Skin in 2015 and holding several senior legal roles.
In his expanded role, he will oversee revenue performance and end-to-end operational execution, including global sales, product innovation, technology platforms, global programs, brand initiatives and legal services across nearly 50 markets. His base salary is $650,000, with a target annual bonus of 75% of base salary.
Clark’s 2026 annual equity award is valued at $2,362,500, split evenly between time-based RSUs and performance-based RSUs. The RSUs vest 25% in each of 2027–2030, while the PRSUs vest in three tranches based on earnings per share performance in 2026, 2027 and 2028.
Nu Skin Enterprises executive Justin S. Keisel reported a tax-related share disposition. On February 26, 2026, 13,687 shares of Nu Skin Class A common stock were withheld at $8.63 per share to cover tax obligations from the vesting of previously granted restricted stock units.
After this non-open-market, tax-withholding disposition, Keisel’s direct holdings totaled 113,111 shares of Class A common stock. This type of transaction is administrative and tied to equity compensation rather than a discretionary share sale.